Pre-Open Stock Movers:
Antares Pharma, Inc. (NASDAQ:ATRS) 49% HIGHER; Halozyme Therapeutics, Inc. (NASDAQ:HALO) agreed to acquire the company for $5.60 per share in cash, or $960 million.
Sierra Oncology, Inc. (NASDAQ:SRRA) 38% HIGHER; GlaxoSmithKline plc (NYSE:GSK) will acquire the company for $55 per share, or $1.9 billion.
NanoString Technologies, Inc. (NASDAQ:NSTG) 33% LOWER; announced preliminary total product and service revenue of approximately $31 million for the first quarter, versus prior guidance of $34-$38 million.
Statera Biopharma, Inc. (NASDAQ:STAB) 18% HIGHER; Enters deal with Coeptis Therapeutics, Inc. (OTC:COEP) to sell rights to toll-like receptor 5 (TLR5) agonist platform.
Liquidia Corporation (NASDAQ:LQDA) 13% LOWER; priced 9,803,922 share offering at $5.10.
BriaCell Therapeutics Corp. (NASDAQ:BCTX) 13% HIGHER; FDA granted Fast Track status to lead candidate, Bria-IMT;
Hillman Solutions Corp. (NASDAQ:HLMN) 11% LOWER; priced upsized 13,000,000 share secondary offering at $10.
Canoo Inc. (NASDAQ:GOEV) 8% HIGHER; selected by NASA to deliver multiple customized all-electric LV models to NASA by June 2023.
Bed Bath & Beyond, Inc. (NASDAQ:BBBY) 8% LOWER; reported Q4 EPS of ($0.92), $0.95 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.07 billion.
VerifyMe, Inc. (NASDAQ:VRME) 7% LOWER; entered into a securities purchase agreement with certain accredited investors to purchase approximately $5.0 million of its common stock.
Delta Air Lines (NYSE:DAL) 5% HIGHER; reported Q1 loss per share $1.23, versus the analyst estimate of -$1.27. Revenue for the quarter came in at $9.3 billion versus the consensus estimate of $8.92 billion.
PayPal Holdings, Inc. (NASDAQ:PYPL) 5% LOWER; CFO John Rainey leaves to join Walmart (NYSE:WMT).
Cardiff Oncology, Inc. (NASDAQ:CRDF) 4% LOWER; chief medical officer Katherine L. Ruffner, M.D. is leaving to pursue a new opportunity.
Affimed N.V. (NASDAQ:AFMD) 3% HIGHER; priced 22,500,000 share offering at $4.
JPMorgan (NYSE:JPM) 3% LOWER; posted Q1 EPS of $2.63,versus the consensus of $2.69. Revenue for the quarter came in at $30.7 billion versus the consensus estimate of $30.86 billion.